Clinical Strategies for Treating Non-alcoholic Fatty Liver Disease with Emphasis on Undigested Concept
Gastroenterology, Inner Mongolia Autonomous Region International Mongolian Medical Hospital, Hohhot 010065, China
| Abstract: | Objective: To elaborate on the clinical strategy and application of emphasizing the concept of undigested treatment for non-alcoholic fatty liver disease. Method: By analyzing the relevant content in ancient and modern Mongolian medical literature such as "Four Parts of Ganlu", "Golden Chamber of Mongolian Medicine", "Internal Medicine of Mongolian Medicine", and combining my clinical experience summary and typical cases to confirm the clinical effect of differentiation and treatment of non-alcoholic fatty liver disease based on the concept of undigested Mongolian medicine. Result: The analysis of relevant literature records is generally consistent with clinical cases. In clinical practice, the premise is to regulate diet and daily life, and the dialectical treatment of non-alcoholic fatty liver disease is based on the principle of regulating stomach fire and aiding digestion. The therapeutic effect is obvious. Conclusion: The treatment of non-alcoholic fatty liver disease can improve the symptoms and indicators of non-alcoholic fatty liver disease by clearing the liver and tonifying the kidney based on indigestion, combined with constitution differentiation and treatment. It is worth further promoting and applying in the field of Mongolian medicine for treating liver disease. To further confirm the therapeutic effect of Mongolian medicine for non-alcoholic fatty liver disease, it is necessary to conduct extensive clinical prospective application research and related molecular mechanisms in the later stage Research in transcriptology, metabolomics, etc. |
| Keywords: | Undigested; Mongolian Medicine Department of Internal Medicine; NAFLD; Clinical Application |
| DOI: | 10.57237/j.cmf.2023.03.002 |
View:
Downloads:
Received: 15 July 2023
Accepted: 25 September 2023
Published Online: 9 October 2023
Funding
| 1. | 第四批全国中医 (少数民族医药) 优秀人才研修项目 (国中医药人教函 (2019) 28号) |
References
| [1] | 图雅. 浅述 «消化不良是内科疾病的起因». 中国蒙医药杂志, 2015, 10: 102-104. |
| [2] | 王小丛. 简述 «未消症是内科诸病之本因». 中国蒙医药杂志, 1989, 3: 6-8. |
| [3] | 特•特木热校注. 四部医典 [M]. 内蒙古科学技术出版社, 1987. |
| [4] | 松巴堪布•益希班觉著, «蒙古医学古籍经典编委会»编译, 松林主编. 甘露四部 [M]. 内蒙古人民出版社, 2015. |
| [5] | 包哈申, 韩九林. «哲对宁诺尔» 研究 [M]. 内蒙古科学技术出版社, 2018. |
| [6] | 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南 (2010年修订版) [J]. 胃肠病学和肝病学杂志, 2010, 19(6): 483-487. |
| [7] | Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis [J]. Gastroenterology, 2020, 158(7): 1913-1928. |
| [8] | YOUNOSSI Z M. Non-alcoholic fatty liver disease - a global public health perspective [J]. Journal of Hepatology, 2019, 70(3): 531-544. |
| [9] | LAZARUS J V, MARK H E, ANSTEE Q M, et al. Advancing the global public health agenda for NAFLD: a consensus statement [J]. Nature Reviews Gastroenterology & Hepatology, 2022, 19(1): 60-78. |
| [10] | Dufour JF, Caussy C, Loomba R. Combination therapy for non-alcoholic steatohepatitis: Rationale, opportunities and challenges [J]. Gut, 2020, 69(10): 1877-1884. |
| [11] | 陈金花. 蒙药治疗脂肪肝临床观察 [J]. 中国民族医药杂志, 2009, 3(3): 17-18. |
| [12] | 风英, 刘金山. 蒙医药治疗非酒精性脂肪肝的临床疗效研究 [J]. 中国民族医药杂志, 2018, 24(09): 7-8. |
| [13] | 美玲, 巴图德力根. 蒙医药治疗非酒精性脂肪肝的研究进展 [J]. 世界最新医学信息文摘, 2019, 19(27): 47+71. |
| [14] | 敖淑霞. 蒙医辨证治疗非酒精性脂肪性肝病临床观察 [J]. 内蒙古民族大学, 硕士学位论文, 2020. |
| [15] | 巴•吉格木德等. 蒙医学基础理论 [M]. 第一版. 内蒙古教育出版社, 1988. |
| [16] | 策•苏荣扎布. 蒙医内科学 [M]. 内蒙古人民出版社, 2011, (3): 112. |
| [17] | 包•纳日斯, 那拉, 哈斯. 蒙西医结合诊治脂肪肝的临床研究 [J]. 中国民族医药杂志, 2007, 13(1): 15-17. |
| [18] | 乌日图那顺, 包纳日斯, 兰英, 等. 通拉嘎-5对酒精性脂肪肝模型大鼠脂质指标的影响 [J]. 中国中医急症, 2014, 23(10): 1779-1781. |
| [19] | 李英, 黄脑日布, 巴图. 蒙药治疗脂肪肝110例临床观察 [J]. 中国民族医药杂志, 2012, 18(3): 7-8. |
| [20] | 李建良. 基于“清浊生华”理论的蒙药五味清浊散抗高脂血症的作用机制初探 [D]. 北京: 中国中医科学院, 2019. |
| [21] | 蔡淑珍, 李建良, 陈圆, 等. 基于网络药理学的荜茇降血脂作用机制研究 [J]. 医药导报, 2019, 38(11): 1398—1402. |
| [22] | 罗布桑泉布勒. 蒙古医学古籍经典丛书-哲对宁诺尔 (蒙文版) [M]. 呼和浩特: 内蒙古人民出版社, 1974: 343. |
| [23] | 吴恩巴雅, 杜凤珍. 蒙药光明盐四味散降血脂作用的研究 [J]. 内蒙古医科大学学报, 1992, 34(1): 10-12. |
| [24] | 黄颖秋. 非酒精性脂肪性肝炎发病机制的研究进展 [J]. 世界华人消化杂志, 2009, 17(31): 3181-3188. |
| [25] | 乌日图那顺, 包纳日斯. 地格达-4对酒精性脂肪肝模型大鼠肝功能的影响 [J]. 西部中医药, 2015, 28(2): 8-10. |
| [26] | 田会萍, 苏荣高娃, 赵贵琴, 等. 蒙药地格达-4 对非酒精性脂肪肝模型大鼠的治疗作用 [J]. 中药药理与临床, 2010, 26(5): 115-116. |
| [27] | Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. [J]. Gut, 2005, 54(1): 142-151. |
| [28] | 戈宏焱, 赵百岁, 张仕华, 等. 蒙药清肝九味散治疗酒精性维化的疗效观察 [J]. 世界华人消化杂志, 2016, 24(32): 4370-4374. |
| [29] | 马月宏, 段申, 金蓉, 等. 蒙药额力根-7 抗大鼠肝纤维化作用研究 [J]. 内蒙古大学学报 (自然科学版), 2016, 47(5): 526-532. |
| [30] | 李岚, 马丽杰. 蒙药古日古木-13对小鼠CCl4肝损伤模型的影响 [J]. 中国民族医药杂志, 2013, 19(2): 57-59. |
| [31] | 苏布德达来. 蒙药红花清肝13味丸治疗肝纤维化大鼠的实验研究 [J]. 北方药学, 2014, 11(5): 74-78. |
| [32] | 娜日苏, 巴图德力根, 韩志强, 等. 德都红花-7 味散对实验性肝纤维化大鼠肝功能和纤维化的影响 [J]. 中医杂志, 2012, 53(24): 2122-2126. |
| [33] | 洪金凤, 巴图德力根, 韩志强, 等. 德都红花-7味散对酒 精性脂肪肝的预防和治疗作用 [J]. 内蒙古民族大学学报 (自然汉文版), 2015, 37(3): 259-263. |
| [34] | 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 中国非酒精性脂肪性肝病诊疗指南 (2010年修订版) [J]. «中国医学前沿杂志 (电子版)», 2012, 4(7): 4-9. |
| [35] | 白清云, 等. 中国医学百科全书•蒙医学 [M]. 蒙语版. 第一版. 内蒙古科学技术出版社, 1987. |
| [36] | 白迎春, 阿如娜等. 蒙药五味清浊散的降血脂药效实验研究. 世界最新医学信息文摘. 2017, 17(34): 191. |
| [37] | 吴哈达, 哈斯巴根, 白福贵. 脂肪肝的蒙医分期论治初探 [J]. 世界最新医学信息文摘, 2017, 17(25): 34-35. |
| [38] | 吴哈达, 温都苏毕力格, 乌恩白乙拉, 锡林其其格. 蒙药优宁八味散防治急性肝损伤的实验研究. 中国民族医药杂志. 2019, 25(05): 32-33. |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us